AGMB insider buying and SEC filings, explained
Agomab Therapeutics NV · CIK 2020932
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$400K
Insiders who bought
3
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 21, 2026 | Purchase (code P) | David R Epstein (Director) bought 10,000 shares at about $8.88 ($89K), reported as a purchase (code P). Holdings up 67% to 25,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 22, 2026, 8:14 AM ET |
| Oct 8, 2026 | Purchase (code P) | David R Epstein (Director) bought 5,000 shares at $8.90 ($45K), reported as a purchase (code P). Holdings up 50% to 15,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 9, 2026, 8:01 AM ET |
| Oct 5–6, 2026 | Purchase (code P) | David R Epstein (Director) bought 10,000 shares between Oct 5 and Oct 6 at about $8.64 ($86K), reported as a purchase (code P). New position of 10,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 8:57 AM ET |
| Oct 6, 2026 | Purchase (code P) | Pierre Thadee Victor Kemula (CFO) bought 10,000 shares at about $8.59 ($86K), reported as a purchase (code P). New position of 10,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 8:47 AM ET |
| Oct 5–6, 2026 | Purchase (code P) | Tim Jasper Knotnerus (CEO and Director) bought 11,000 shares between Oct 5 and Oct 6 at about $8.58 ($94K), reported as a purchase (code P). Holdings up 102% to 21,823 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 8:06 AM ET |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$400K in purchases since Oct 6, 2026 · Purchases traded Oct 6, 2026 to Oct 21, 2026 · Active
| Insider | Value | Traded | Source |
|---|---|---|---|
| David R Epstein (Director) | $86K | Oct 6, 2026 | SEC filing |
| Tim Jasper Knotnerus (CEO) | $94K | Oct 6, 2026 | SEC filing |
| Pierre Thadee Victor Kemula (CFO) | $86K | Oct 6, 2026 | SEC filing |
| David R Epstein (Director) | $45K | Oct 8, 2026 | SEC filing |
| David R Epstein (Director) | $89K | Oct 21, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AGMB in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.